
|Articles|November 15, 2021
Pharmacy Clinical Pearl of the Day: Liver Cancer
Author(s)Saro Arakelians, PharmD
Risk factors for liver cancer include chronic infection with hepatitis B or hepatitis C virus, cirrhosis, diabetes, and non-alcoholic fatty liver disease.
Advertisement
Clinical Pearl of the Day: Liver Cancer
Liver cancer begins in the cells of the liver.
Insight:
- The most common type of liver cancer is hepatocellular carcinoma, which begins in the main type of liver cell (hepatocyte).
- Some of the symptoms include weight loss, appetite loss, upper abdominal pain, vomiting, general weakness, abdominal swelling, white and chalky stool.
- Risk factors include chronic infection with hepatitis B or hepatitis C virus, cirrhosis, inherited liver diseases, diabetes, non-alcoholic fatty liver disease, and alcohol consumption.
- Diagnosis includes blood test, imaging tests, and removing a sample of the liver for biopsy.
- Treatment includes surgery, targeted drug therapy, immunotherapy, chemotherapy, and supportive care.
- Some of the chemotherapy drugs include gemcitabine (Gemzar), oxaliplatin (Eloxatin), cisplatin, doxorubicin (pegylated liposomal doxorubicin), 5-fluorouracil (5-FU), capecitabine (Xeloda), and mitoxantrone (Novantrone).
- Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement













































































































































































































